|
2026 Journal Article Correction: Berezowski et al. Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study. Cancers 2025, 17, 2588Berezowski, Brett, Boothe, Robert, Chaplin, Billy, Del Vecchio, Sharon J., Fares, Zakariya, Humphries, Tyrone L. R., Ng, Keng Lim, Noonan, Taylor, Samaratunga, Hemamali, Urquhart, Aaron, Vesey, David A., Wood, Simon T., Gobe, Glenda C. and Ellis, Robert J. (2026). Correction: Berezowski et al. Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study. Cancers 2025, 17, 2588. Cancers, 18 (10) 1549, 1549. doi: 10.3390/cancers18101549 |
|
2025 Journal Article Biomarkers in renal cell carcinoma: a systematic review and immunohistochemical validation studyBerezowski, Brett, Boothe, Robert, Chaplin, Billy, Del Vecchio, Sharon J., Fares, Zakariya, Humphries, Tyrone L. R., Ng, Keng Lim, Noonan, Taylor, Samaratunga, Hemamali, Urquhart, Aaron, Vesey, David A., Wood, Simon T., Gobe, Glenda C. and Ellis, Robert J. (2025). Biomarkers in renal cell carcinoma: a systematic review and immunohistochemical validation study. Cancers, 17 (15) 2588, 2588-15. doi: 10.3390/cancers17152588 |
|
2025 Journal Article Head-to-head comparison of tyrosine kinase inhibitors in renal cell carcinoma using patient-derived cell cultureUrquhart, Aaron J., Glass, Christian H., Humphries, Tyrone L. R., Kassianos, Andrew J., Vesey, David A., Wood, Simon T., Gobe, Glenda C. and Ellis, Robert J. (2025). Head-to-head comparison of tyrosine kinase inhibitors in renal cell carcinoma using patient-derived cell culture. Personalized Medicine, 22 (2), 83-91. doi: 10.1080/17410541.2025.2473303 |
|
2025 Journal Article Metabolite pathway alterations identified by magnetic resonance metabolomics in a proximal tubular epithelial cell line treated with TGF‐β1Humphries, Tyrone L. R., Lee, Soobin, Urquhart, Aaron J., Vesey, David A., Micallef, Aaron S., Winterford, Clay, Kassianos, Andrew J., Galloway, Graham J., Francis, Ross S. and Gobe, Glenda C. (2025). Metabolite pathway alterations identified by magnetic resonance metabolomics in a proximal tubular epithelial cell line treated with TGF‐β1. Physiological Reports, 13 (4) e70249, e70249. doi: 10.14814/phy2.70249 |
|
2024 Journal Article Identifying biochemical changes in the kidney using proton nuclear magnetic resonance in an adenine diet chronic kidney disease mouse modelHumphries, Tyrone L. R., Gobe, Glenda C., Urquhart, Aaron J., Ellis, Robert J., Galloway, Graham J., Vesey, David A. and Francis, Ross S. (2024). Identifying biochemical changes in the kidney using proton nuclear magnetic resonance in an adenine diet chronic kidney disease mouse model. NMR in Biomedicine, 37 (12) e5257, e5257. doi: 10.1002/nbm.5257 |
|
2023 Journal Article Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopyUrquhart, Aaron J., Del Vecchio, Sharon J., Lukas, Darren, Ellis, Robert J., Humphries, Tyrone L.R., Ng, Keng Lim, Samaratunga, Hemamali, Galloway, Graham J., Gobe, Glenda C., Wood, Simon T. and Mountford, Carolyn E. (2023). Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopy. Advances in Biomarker Sciences and Technology, 5, 68-75. doi: 10.1016/j.abst.2023.08.001 |
|
2023 Journal Article Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopyHumphries, Tyrone L.R., Vesey, David A., Galloway, Graham J., Gobe, Glenda C. and Francis, Ross S. (2023). Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy. Progress in Nuclear Magnetic Resonance Spectroscopy, 134-135, 52-64. doi: 10.1016/j.pnmrs.2023.04.001 |
|
2021 Journal Article PAR2-induced tissue factor synthesis by primary cultures of human kidney tubular epithelial cells is modified by glucose availabilityHumphries, Tyrone L. R., Shen, Kunyu, Iyer, Abishek, Johnson, David W., Gobe, Glenda C., Nikolic-Paterson, David, Fairlie, David P. and Vesey, David A. (2021). PAR2-induced tissue factor synthesis by primary cultures of human kidney tubular epithelial cells is modified by glucose availability. International Journal of Molecular Sciences, 22 (14) 7532, 1-12. doi: 10.3390/ijms22147532 |
|
2021 Journal Article PAR2 activation on human kidney tubular epithelial cells induces tissue factor synthesis, that enhances blood clottingIyer, Abishek, Humphries, Tyrone L. R., Owens, Evan P., Zhao, Kong-Nan, Masci, Paul P., Johnson, David W., Nikolic-Paterson, David, Gobe, Glenda C., Fairlie, David P. and Vesey, David A. (2021). PAR2 activation on human kidney tubular epithelial cells induces tissue factor synthesis, that enhances blood clotting. Frontiers in Physiology, 12 615428, 615428. doi: 10.3389/fphys.2021.615428 |
|
2021 Journal Article Progress curve analysis of microtitre plate plasma clotting assays. Assessment of tissue factor levelsHumphries, Tyrone L.R., Johnson, Lambro A., Masci, Paul P., Gobe, Glenda C. and Vesey, David A. (2021). Progress curve analysis of microtitre plate plasma clotting assays. Assessment of tissue factor levels. Analytical Biochemistry, 614 114060, 114060. doi: 10.1016/j.ab.2020.114060 |
|
2020 Journal Article Development of a biomarker panel to distinguish risk of progressive chronic kidney diseaseOwens, Evan, Tan, Ken-Soon, Ellis, Robert, Del Vecchio, Sharon, Humphries, Tyrone, Lennan, Erica, Vesey, David, Healy, Helen, Hoy, Wendy and Gobe, Glenda (2020). Development of a biomarker panel to distinguish risk of progressive chronic kidney disease. Biomedicines, 8 (12) 606, 606-16. doi: 10.3390/biomedicines8120606 |
